Capital Rx Named Winner of 2021 Edison Award 
Cloud DX Awarded Silver at the 2021 Edison Awards Capital Rx Named Winner of 2021 Edison Award
Company’s Clearinghouse ModelTM, Designed to Simplify Prescription Drug Pricing, Captures Silver Award NEW YORK–(BUSINESS WIRE)–Capital…
Cloud DX Awarded Silver at the 2021 Edison Awards
BROOKLYN, NY and KITCHENER, ON / ACCESSWIRE / April 23, 2021 / Cloud DX (TSXV:CDX) a leading…
Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Annual General Meeting on 15 June 2021
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No…
Meningitis Canada Urges Policy Makers to Help Defeat Meningitis
WATERLOO, Ontario, April 23, 2021 (GLOBE NEWSWIRE) — This World Meningitis Day (April 24th), Meningitis…
Cronos Group Inc. to Hold 2021 First Quarter Earnings Conference Call on May 7, 2021
TORONTO, April 23, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
Coherus Announces Toripalimab Achieved Primary Endpoints of Progression Free Survival and Overall Survival in Interim Analysis of Phase 3 Clinical Trial in First-Line Esophageal Squamous Cell Carcinoma
REDWOOD CITY, Calif., April 23, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Nasdaq: CHRS) has…
DLH Wins Follow-On Contract for CMOP Medical Logistics for the Department of Veterans Affairs
Five Year Value of $202 Million ATLANTA, April 23, 2021 (GLOBE NEWSWIRE) — DLH Holdings…
Vaxart Appoints David Wheadon, M.D., to its Board of Directors
SOUTH SAN FRANCISCO, Calif., April 23, 2021 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage…
Timber Pharmaceuticals Announces Appointment of John Koconis as Chairman of the Board of Directors
– Edward J. Sitar appointed as Lead Independent Director of the Board – – Company…
ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Extension Trial Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a…